Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 231

The DOI matches its Crossref record.

Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status

Nesaretnam, Kalanithi, Stephen, Ruth, Dils, Ray, Darbre, Philippa · 1998 · Lipids

Abstract

Potential antiproliferative effects of tocotrienols, the major vitamin E component in palm oil, were investigated on the growth of both estrogen‐responsive (ER+) MCF7 human breast cancer cells and estrogen‐unresponsive (ER‐) MDA‐MD‐231 human breast cancer cells, and effects were compared with those of α‐tocopherol (αT). The tocotrienol‐rich fraction (TRF) of palm oil inhibited growth of MCF7 cells in both the presence and absence of estradiol with a nonlinear dose‐response but such that complete suppression of growth was achieved at 8 μg/mL. MDA‐MB‐231 cells were also inhibited by TRF but with a linear dose‐response such that 20 μg/mL TRF was needed for complete growth suppression. Separation of the TRF into individual tocotrienols revealed that all fractions could inhibit growth of both ER+ and ER‐ cells and of ER+ cells in both the presence and absence of estradiol. However, the γ‐ and δ‐fractions were the most inhibitory. Complete inhibition of MCF7 cell growth was achieved at 6 μg/mL of γ‐tocotrienol/δ‐tocotrienol (γT 3/δT 3) in the absence of estradiol and 10μm/mL of δT 3 in the presence of estradiol, whereas complete suppression of MDA‐MB‐231 cell growth was not achieved even at concentrations of 10μg/mL of δT 3. By contrast to these inhibitory effects of tocotrienols, αT had no inhibitory effect on MCF7 cell growth in either the presence or the absence of estradiol, nor on MDA‐MB‐231 cell growth. These results confirm studies using other sublines of human breast cancer cells and demonstrate that tocotrienols can exert direct inhibitory effects on the growth of breast cancer cells. In searching for the mechanism of inhibition, studies of the effects of TRF on estrogen‐regulated pS2 gene expression in MCF7 cells showed that tocotrienols do not act via an estrogen receptor‐mediated pathway and must therefore act differently from estrogen antagonists. Furthermore, tocotrienols did not increase levels of growth‐inhibitory insulin‐like growth factor binding proteins (IGFBP) in MCF7 cells, implying also a different mechanism from that proposed for retinoic acid inhibition of estrogen‐responsive breast cancer cell growth. Inhibition of the growth of breast cancer cells by tocotrienols could have important clinical implications not only because tocotrienols are able to inhibit the growth of both ER+ and ER‐ phenotypes but also because ER+ cells could be growth‐inhibited in the presence as well as in the absence of estradiol. Future clinical applications of TRF could come from potential growth suppression of ER+ breast cancer cells otherwise resistant to growth inhibition by antiestrogens and retinoic acid.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11745-998-0229-3

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 231

Metadata

Authors
Nesaretnam, K., Stephen, R., Dils, R., & Darbre, P.
Venue
Lipids
Publisher
Wiley
Published
1998-05
Volume
33
Issue
5
Pages
461-9
ISSN
  • 0024-4201 (ISSN-L)
  • 1558-9307
OpenAlex
W2070638683
Cited by
231
References
0
FWCI
6.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. https://app.cochat.ai/papers/10.1007/s11745-998-0229-3
The paper
Nesaretnam, K., Stephen, R., Dils, R., & Darbre, P. (1998). Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids. https://doi.org/10.1007/s11745-998-0229-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.